Thrilled to Welcome Washington Dengu to QUAMED!

Exciting News! We’re thrilled to share that Washington DENGU will be joining QUAMED as Technical Deputy Director on a 0.5FTE basis starting November 1st! Washington brings over 15 years of experience in pharmaceutical manufacturing and regulatory affairs, and continues to lead and shape Africa’s regulatory landscape actively. He brings in a wealth of experience, which ...

Bridging the Gaps in Access to Essential Medicines

Access to essential medicines remains uneven worldwide. A study in India’s aspirational districts showed encouraging progress, with most treatments affordable and widely available. In stark contrast, Sudan’s civil war has led to severe shortages and unaffordable prices, leaving many without life-saving drugs. Meanwhile, Brazil continues to face systemic barriers, economic inequalities, import dependence, and limited ...

WHO Medical Alert: Contaminated Oral Medicines Identified in India

The World Health Organization has issued a warning after detecting Diethylene Glycol (DEG) contamination in three oral liquid medicines, COLDRIF, Respifresh TR, and ReLife, linked to child fatalities in India. These products, commonly used for cold, flu, and cough relief, are toxic and potentially fatal, especially for children. While no exports have been reported, WHO urges all ...

The Global Challenge of Poor-Quality Medicines in LMICs

A recent chapter titled “The Current Situation of Medicines Quality in Low- and Middle-Income Countries: New Challenges to be Addressed” (IntechOpen, 2025) sheds light on a growing global health concern: 10.5% of medicines worldwide are of poor quality, with the greatest impact seen in low- and middle-income countries. Harsh climates, weak regulatory systems, and fragmented supply ...

WHO Recognizes Ethiopia’s Regulatory Milestone

Ethiopia has reached a major milestone in medicines regulation, achieving WHO Maturity Level 3 (ML3)! This recognition highlights the Ethiopian Food and Drug Authority’s commitment to ensuring that medicines and vaccines meet international standards of quality, safety, and efficacy. Ethiopia now joins eight other African countries in demonstrating strong, well-functioning regulatory systems that protect public ...

Why QCP Matters

Having a GSDP, GMP, or MQAS assessment is not just a box-ticking exercise; it is essential to ensure that your pharmaceutical systems meet internationally recognised standards of quality and safety. These assessments are critical for building trust, protecting patients, and strengthening your position in the market. The Quamed Quality Certification Program (QCP) is significant because ...

Barriers & Solutions Workshop on Local Procurement in Kabul

Today in Kabul, the Quamed and Relief International team conducted our Barriers & Solutions Workshop, focused on how to best facilitate local procurement of quality medical products in Afghanistan. Internet was still offline, which impeded registered turnout, but we had vibrant interactive discussions with over 35 external participants, with an even mix between government authorities, ...

Working Together for Quality Medicines

From September 9 to 11, 2025, we had the privilege of facilitating a World Health Organisation workshop in Brazzaville, Republic of the Congo, focused on capacity building in quality assurance for the Procurement of Medical Products. Together with WHO AFRO, WHO HQ, and our QUAMED team, we worked with 25 participants from WHO regional and ...

Rafaella’s Literature Update

The following message is courtesy of Dr. Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium Dear Friends, The safe elimination of pharmaceutical (and laboratory!) waste is a critical component of the pharmaceutical life cycle, but it remains, at best, an afterthought for funders, researchers and policymakers, leaving many communities exposed to preventable ...

Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.